stp_bannerlogocombo twitter facebook employee contact

Synergy Therapeutic Partners (STP) is a premier multi-centered clinical research organization that conducts highly efficient clinical trials for the pharmaceutical industry. "Our Vision is to provide best practices in clinical research for the advancement of modern day medicine." Our staff has a combined experience of 15 years offering the "We Care" attitude to our patients and stakeholders. We are committed to serving our communities with best practices and innovating ideas that will positively impact the medical industry.

Welcome to Synergy Therapeutic Partners

"Today’s Standard Treatment was Yesterday’s Clinical Trial"

Synergy Therapeutic Partners (STP) provides efficient and high quality Phase II, III, IV, and over-the-counter clinical trials to the pharmaceutical industry.  Our staff is committed to the advancement of modern medicine by providing our clients with reliable and expeditious services.  We serve as the connecting force in meeting and exceeding expectations in patient recruitment and regulatory processing.

lg_test_tubes

STP is committed to making clinical trials accessible across diverse populations and providing patients with optimal care.  We ensure each patient is well-informed about the clinical research process. Please feel free to view the FAQs to learn more about participating in a clinical trial.   

FDA Drug Info Rounds
Drug Name Review
FDA Drug Info Rounds pharmacists discuss FDA's ...

Communicating Benefit and ...
FDA Drug Info Rounds pharmacists talk about the ...

Communicating Drug Safety ...
FDA Drug Info Rounds pharmacists discuss the ...

Drug Shortages Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Evamist Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Proton Pump Inhibitors (PPIs) ...
FDA Drug Info Rounds pharmacists discuss new ...

Long-Acting Beta-Agonists ...
Long-Acting Beta-Agonists (LABAs), a class of ...

Single-Ingredient Oral ...
FDA Drug Info Rounds pharmacists discuss the ...

NIH News Releases
Ebola test vaccines appear ...
Liberia–U.S. partnership planning Phase 3 trial ...

NIH study finds no evidence ...
The study compares virus sequencing data from ...

HIV can spread early, evolve ...
Findings add urgency to screening, treatment – ...

Update on clinical status of ...
Status changes from critical to serious condition.

New NIMH strategic plan aims ...
SNational Institute of Mental Health plan will ...

NIH statement on World TB Day ...
Statement of Christine F. Sizemore, Ph.D., ...

NIH selects awardees to help ...
Program will foster the development of ...

For most children with HIV ...
NIH-funded study finds T-cell level returns to ...

Strengthening the immune ...
NIH-funded research suggests novel way to improve ...

NIH holds competition to ...
First prize winner will be awarded $200,000.

Update on clinical status of ...
Status changes from serious to critical condition.

NIH announces Follow that ...
Challenge seeks new tools to enable researchers ...

Anti-herpes drug may help ...
Drug appears to reduce the levels of HIV in ...

UPDATE: American healthcare ...
Patient admitted to NIH Clinical Center’s ...

NIH to admit American ...
Patient will be treated at the NIH Clinical ...

NIH works to improve kidney ...
Statement of NIDDK Director Griffin P. Rodgers, ...

Study reveals how genetic ...
NIH-funded research suggests novel approach for ...

NIH-funded scientists ...
Finding suggests potential strategies for ...

Physical labor, hypertension ...
NIH-funded study analyzes data from more than 450 ...

NIH-led study to assess ...
The study is being conducted as part of the D.C. ...

Dr. Gary Wand to deliver 7th ...
The Mendelson Honorary Lecture is free and open ...

Varmus Stepping Down as ...
Harold Varmus, M.D., leaving post as NCI Director ...

NIH-led effort launches Big ...
Innovative collaboration, rapid data-sharing ...